Cite
Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong In Vitro Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds.
MLA
Schell, W. A., et al. “Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong In Vitro Activity against Candida Glabrata and C. Krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds.” Antimicrobial Agents and Chemotherapy, vol. 61, no. 3, Feb. 2017. EBSCOhost, https://doi.org/10.1128/AAC.01817-16.
APA
Schell, W. A., Jones, A. M., Garvey, E. P., Hoekstra, W. J., Schotzinger, R. J., & Alexander, B. D. (2017). Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong In Vitro Activity against Candida glabrata and C. krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds. Antimicrobial Agents and Chemotherapy, 61(3). https://doi.org/10.1128/AAC.01817-16
Chicago
Schell, W A, A M Jones, E P Garvey, W J Hoekstra, R J Schotzinger, and B D Alexander. 2017. “Fungal CYP51 Inhibitors VT-1161 and VT-1129 Exhibit Strong In Vitro Activity against Candida Glabrata and C. Krusei Isolates Clinically Resistant to Azole and Echinocandin Antifungal Compounds.” Antimicrobial Agents and Chemotherapy 61 (3). doi:10.1128/AAC.01817-16.